CellR4 2021; 9: e3058
DOI: 10.32113/cellr4_20212_3058

The role of Th17 cells in SARS-CoV-2 infection: implementation for the therapy of severe COVID-19 cases

CellR4 2021; 9: e3060
DOI: 10.32113/cellr4_20212_3060

Adipose-derived Stromal Vascular Matrix (SVM): a new paradigm in regenerative medicine

CellR4 2020; 8: e2986
DOI: 10.32113/cellr4_202012_2986

Brown adipose tissue transplantation as a promising approach for insulin-independent reversal of type 1 diabetes: animal studies and clinical perspectives

CellR4 2020; 8: e2955
DOI: 10.32113/cellr4_202010_2955

Human islet distribution during COVID-19 pandemic: the impact on diabetes research

CellR4 2020; 8: e2957
DOI: 10.32113/cellr4_202010_2957

Islet cell transplantation: the effects of COVID-19 pandemic

CellR4 2020; 8: e2943
DOI: 10.32113/cellr4_202010_2943

GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction

CellR4 2020; 8: e2945
DOI: 10.32113/cellr4_202010_2945

Involvement of gut microbiota in solid organ transplantation

CellR4 2020; 8: e2939
DOI: 10.32113/cellr4_202010_2939

Mesenchymal stem cell-derived exosomes for the treatment of pulmonary diseases

CellR4 2020; 8: e2898
DOI: 10.32113/cellr4_20209_2898

The new antidiabetic agents: cardiovascular and renal protection in post-transplant diabetes mellitus

CellR4 2020; 8: e2894
DOI: 10.32113/cellr4_20209_2894

Advances in stem cell-based therapy for hair loss